Upgrades
Scotiabank upgraded the previous rating for Mirati Therapeutics Inc MRTX from Sector Underperform to Sector Perform. For the second quarter, Mirati Therapeutics had an EPS of $3.04, compared to year-ago quarter EPS of $3.18. At the moment, the stock has a 52-week-high of $101.20 and a 52-week-low of $27.30. Mirati Therapeutics closed at $60.20 at the end of the last trading period.
According to Loop Capital, the prior rating for MSC Industrial Direct Co Inc MSM was changed from Hold to Buy. For the third quarter, MSC Industrial Direct Co had an EPS of $1.74, compared to year-ago quarter EPS of $1.82. The stock has a 52-week-high of $103.95 and a 52-week-low of $72.97. At the end of the last trading period, MSC Industrial Direct Co closed at $99.72.
For Patterson-UTI Energy Inc PTEN, Citigroup upgraded the previous rating of Neutral to Buy. Patterson-UTI Energy earned $0.43 in the second quarter, compared to $0.05 in the year-ago quarter. The stock has a 52-week-high of $19.81 and a 52-week-low of $9.70. At the end of the last trading period, Patterson-UTI Energy closed at $12.32.
According to Evercore ISI Group, the prior rating for Oracle Corp ORCL was changed from In-Line to Outperform. In the first quarter, Oracle showed an EPS of $1.19, compared to $1.03 from the year-ago quarter. The stock has a 52-week-high of $127.54 and a 52-week-low of $61.66. At the end of the last trading period, Oracle closed at $109.96.
For Lennox International Inc LII, Goldman Sachs upgraded the previous rating of Sell to Buy. For the second quarter, Lennox Intl had an EPS of $6.15, compared to year-ago quarter EPS of $5.00. The stock has a 52-week-high of $393.02 and a 52-week-low of $203.82. At the end of the last trading period, Lennox Intl closed at $373.62.
For Aramark ARMK, Jefferies upgraded the previous rating of Hold to Buy. For the third quarter, Aramark had an EPS of $0.36, compared to year-ago quarter EPS of $0.25. At the moment, the stock has a 52-week-high of $45.72 and a 52-week-low of $23.95. Aramark closed at $24.60 at the end of the last trading period.
According to Baird, the prior rating for On Holding AG ONON was changed from Neutral to Outperform. On Holding earned $0.04 in the second quarter, compared to $0.15 in the year-ago quarter. The stock has a 52-week-high of $37.08 and a 52-week-low of $15.44. At the end of the last trading period, On Holding closed at $25.11.
For Zscaler Inc ZS, Barclays upgraded the previous rating of Equal-Weight to Overweight. Zscaler earned $0.64 in the fourth quarter, compared to $0.25 in the year-ago quarter. The current stock performance of Zscaler shows a 52-week-high of $185.90 and a 52-week-low of $84.93. Moreover, at the end of the last trading period, the closing price was at $163.59.
See all analyst ratings upgrades.
Downgrades
Ladenburg Thalmann downgraded the previous rating for Dynatronics Corp DYNT from Buy to Neutral. In the fourth quarter, Dynatronics showed an EPS of $0.63, compared to $0.50 from the year-ago quarter. The current stock performance of Dynatronics shows a 52-week-high of $2.73 and a 52-week-low of $0.69. Moreover, at the end of the last trading period, the closing price was at $0.69.
B. Riley Securities downgraded the previous rating for Mirati Therapeutics Inc MRTX from Buy to Neutral. Mirati Therapeutics earned $3.04 in the second quarter, compared to $3.18 in the year-ago quarter. At the moment, the stock has a 52-week-high of $101.20 and a 52-week-low of $27.30. Mirati Therapeutics closed at $60.20 at the end of the last trading period.
For Apollo Global Management Inc APO, Oppenheimer downgraded the previous rating of Outperform to Perform. For the second quarter, Apollo Global Management had an EPS of $1.70, compared to year-ago quarter EPS of $0.94. The stock has a 52-week-high of $93.18 and a 52-week-low of $45.63. At the end of the last trading period, Apollo Global Management closed at $90.57.
According to Oppenheimer, the prior rating for Blue Owl Capital Inc OWL was changed from Outperform to Perform. For the second quarter, Blue Owl Cap had an EPS of $0.16, compared to year-ago quarter EPS of $0.13. The current stock performance of Blue Owl Cap shows a 52-week-high of $14.04 and a 52-week-low of $8.06. Moreover, at the end of the last trading period, the closing price was at $13.65.
According to Raymond James, the prior rating for AeroVironment Inc AVAV was changed from Strong Buy to Outperform. In the first quarter, AeroVironment showed an EPS of $1.00, compared to $0.10 from the year-ago quarter. The current stock performance of AeroVironment shows a 52-week-high of $124.33 and a 52-week-low of $74.91. Moreover, at the end of the last trading period, the closing price was at $105.02.
For Datadog Inc DDOG, B of A Securities downgraded the previous rating of Buy to Neutral. In the second quarter, Datadog showed an EPS of $0.36, compared to $0.24 from the year-ago quarter. At the moment, the stock has a 52-week-high of $118.02 and a 52-week-low of $61.34. Datadog closed at $94.43 at the end of the last trading period.
Evercore ISI Group downgraded the previous rating for Splunk Inc SPLK from Outperform to In-Line. In the second quarter, Splunk showed an EPS of $0.71, compared to $0.09 from the year-ago quarter. At the moment, the stock has a 52-week-high of $147.14 and a 52-week-low of $65.00. Splunk closed at $146.70 at the end of the last trading period.
For Zurn Elkay Water Solutions Corp ZWS, Goldman Sachs downgraded the previous rating of Buy to Neutral. Zurn Elkay Water earned $0.24 in the second quarter, compared to $0.32 in the year-ago quarter. At the moment, the stock has a 52-week-high of $30.87 and a 52-week-low of $19.29. Zurn Elkay Water closed at $26.46 at the end of the last trading period.
According to Redburn Atlantic, the prior rating for Spotify Technology SA SPOT was changed from Buy to Neutral. In the second quarter, Spotify Technology showed an EPS of $1.69, compared to $0.91 from the year-ago quarter. At the moment, the stock has a 52-week-high of $182.00 and a 52-week-low of $69.41. Spotify Technology closed at $160.53 at the end of the last trading period.
According to Jefferies, the prior rating for Mirati Therapeutics Inc MRTX was changed from Buy to Hold. Mirati Therapeutics earned $3.04 in the second quarter, compared to $3.18 in the year-ago quarter. The current stock performance of Mirati Therapeutics shows a 52-week-high of $101.20 and a 52-week-low of $27.30. Moreover, at the end of the last trading period, the closing price was at $60.20.
Barclays downgraded the previous rating for Tenable Holdings Inc TENB from Overweight to Equal-Weight. For the second quarter, Tenable Holdings had an EPS of $0.22, compared to year-ago quarter EPS of $0.05. The current stock performance of Tenable Holdings shows a 52-week-high of $49.77 and a 52-week-low of $28.80. Moreover, at the end of the last trading period, the closing price was at $46.15.
For Mirati Therapeutics Inc MRTX, JMP Securities downgraded the previous rating of Market Outperform to Market Perform. In the second quarter, Mirati Therapeutics showed an EPS of $3.04, compared to $3.18 from the year-ago quarter. The stock has a 52-week-high of $101.20 and a 52-week-low of $27.30. At the end of the last trading period, Mirati Therapeutics closed at $60.20.
See all analyst ratings downgrades.
Initiations
With a Buy rating, Jefferies initiated coverage on Laureate Education Inc LAUR. The price target seems to have been set at $20.00 for Laureate Education. For the second quarter, Laureate Education had an EPS of $0.35, compared to year-ago quarter EPS of $0.25. At the moment, the stock has a 52-week-high of $14.80 and a 52-week-low of $9.24. Laureate Education closed at $14.10 at the end of the last trading period.
Loop Capital initiated coverage on ARM Holdings PLC ARM with a Buy rating. The price target for ARM Holdings is set to $69.00. The stock has a 52-week-high of $69.00 and a 52-week-low of $49.85. At the end of the last trading period, ARM Holdings closed at $54.08.
With a Buy rating, Rosenblatt initiated coverage on ARM Holdings PLC ARM. The price target seems to have been set at $85.00 for ARM Holdings. At the moment, the stock has a 52-week-high of $69.00 and a 52-week-low of $49.85. ARM Holdings closed at $54.08 at the end of the last trading period.
Wolfe Research initiated coverage on ARM Holdings PLC ARM with a Peer Perform rating. The current stock performance of ARM Holdings shows a 52-week-high of $69.00 and a 52-week-low of $49.85. Moreover, at the end of the last trading period, the closing price was at $54.08.
B of A Securities initiated coverage on ARM Holdings PLC ARM with a Buy rating. The price target for ARM Holdings is set to $65.00. The current stock performance of ARM Holdings shows a 52-week-high of $69.00 and a 52-week-low of $49.85. Moreover, at the end of the last trading period, the closing price was at $54.08.
With an Outperform rating, BMO Capital initiated coverage on Prime Medicine Inc PRME. The price target seems to have been set at $19.00 for Prime Medicine. Prime Medicine earned $0.47 in the second quarter, compared to $1.76 in the year-ago quarter. At the moment, the stock has a 52-week-high of $21.60 and a 52-week-low of $8.46. Prime Medicine closed at $8.88 at the end of the last trading period.
HC Wainwright & Co. initiated coverage on Scilex Holding Co SCLX with a Buy rating. The price target for Scilex Holding is set to $12.00. For the second quarter, Scilex Holding had an EPS of $0.19, compared to year-ago quarter EPS of $0.13. At the moment, the stock has a 52-week-high of $16.90 and a 52-week-low of $1.21. Scilex Holding closed at $1.57 at the end of the last trading period.
Mizuho initiated coverage on ARM Holdings PLC ARM with a Buy rating. The price target for ARM Holdings is set to $62.00. The stock has a 52-week-high of $69.00 and a 52-week-low of $49.85. At the end of the last trading period, ARM Holdings closed at $54.08.
With a Buy rating, Guggenheim initiated coverage on ARM Holdings PLC ARM. The price target seems to have been set at $64.00 for ARM Holdings. The stock has a 52-week-high of $69.00 and a 52-week-low of $49.85. At the end of the last trading period, ARM Holdings closed at $54.08.
With an Outperform rating, TD Cowen initiated coverage on ARM Holdings PLC ARM. The price target seems to have been set at $63.00 for ARM Holdings. At the moment, the stock has a 52-week-high of $69.00 and a 52-week-low of $49.85. ARM Holdings closed at $54.08 at the end of the last trading period.
Jefferies initiated coverage on ARM Holdings PLC ARM with a Buy rating. The price target for ARM Holdings is set to $64.00. The current stock performance of ARM Holdings shows a 52-week-high of $69.00 and a 52-week-low of $49.85. Moreover, at the end of the last trading period, the closing price was at $54.08.
Deutsche Bank initiated coverage on ARM Holdings PLC ARM with a Buy rating. The price target for ARM Holdings is set to $60.00. At the moment, the stock has a 52-week-high of $69.00 and a 52-week-low of $49.85. ARM Holdings closed at $54.08 at the end of the last trading period.
JP Morgan initiated coverage on ARM Holdings PLC ARM with an Overweight rating. The price target for ARM Holdings is set to $70.00. The current stock performance of ARM Holdings shows a 52-week-high of $69.00 and a 52-week-low of $49.85. Moreover, at the end of the last trading period, the closing price was at $54.08.
Baird initiated coverage on Calidi Biotherapeutics Inc CLDI with an Outperform rating. The price target for Calidi Biotherapeutics is set to $9.00. The stock has a 52-week-high of $5.00 and a 52-week-low of $2.60. At the end of the last trading period, Calidi Biotherapeutics closed at $2.92.
BMO Capital initiated coverage on ARM Holdings PLC ARM with a Market Perform rating. The price target for ARM Holdings is set to $60.00. The current stock performance of ARM Holdings shows a 52-week-high of $69.00 and a 52-week-low of $49.85. Moreover, at the end of the last trading period, the closing price was at $54.08.
Barclays initiated coverage on ARM Holdings PLC ARM with an Overweight rating. The price target for ARM Holdings is set to $65.00. The stock has a 52-week-high of $69.00 and a 52-week-low of $49.85. At the end of the last trading period, ARM Holdings closed at $54.08.
Citigroup initiated coverage on ARM Holdings PLC ARM with a Buy rating. The price target for ARM Holdings is set to $65.00. At the moment, the stock has a 52-week-high of $69.00 and a 52-week-low of $49.85. ARM Holdings closed at $54.08 at the end of the last trading period.
With a Buy rating, Goldman Sachs initiated coverage on ARM Holdings PLC ARM. The price target seems to have been set at $62.00 for ARM Holdings. The current stock performance of ARM Holdings shows a 52-week-high of $69.00 and a 52-week-low of $49.85. Moreover, at the end of the last trading period, the closing price was at $54.08.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.